Original Research
Accepted on 27 Nov 2025
Transarterial chemoembolization with rivoceranib and camrelizumab for BCLC stage C hepatocellular carcinoma
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Original Research
Accepted on 27 Nov 2025
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Original Research
Accepted on 27 Nov 2025
in STEM Education
Original Research
Accepted on 27 Nov 2025
in Virology
Original Research
Accepted on 27 Nov 2025
in Aquatic Microbiology
Original Research
Accepted on 27 Nov 2025
in Food Microbiology
Original Research
Accepted on 27 Nov 2025
in Alloimmunity and Transplantation
Original Research
Accepted on 27 Nov 2025
in Fluid Mechanics
Original Research
Accepted on 27 Nov 2025
in Animal Conservation
Mini Review
Accepted on 27 Nov 2025
in Structure, Spectroscopy & Imaging
Original Research
Accepted on 27 Nov 2025
in Animal Nutrition and Metabolism
Review
Accepted on 27 Nov 2025
in Pathology
Case Report
Accepted on 27 Nov 2025
in Genitourinary Oncology
Original Research
Accepted on 27 Nov 2025
in Intensive Care Medicine and Anesthesiology
Original Research
Accepted on 27 Nov 2025
in Healthcare Professions Education
Original Research
Accepted on 27 Nov 2025
in Healthcare Professions Education
Original Research
Accepted on 27 Nov 2025
in Healthcare Professions Education